-
Sector Analysis
New Drug Approvals and Their Contract Manufacture – 2023 Edition
Explore actionable market insights from the following data in our ‘New Drug Approvals and Their Contract Manufacture’ report. This report is required reading for - CMO executives who must have a deep understanding of drug approvals and outsourcing to make strategic planning and investment decisions. Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. Private equity investors who need a deeper understanding of the market to...
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Sector Analysis
Supportive Care in Cancer – Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet Needs
Supportive care in cancer is an evolving discipline of medicine that is critical for holistic management of patients with cancer. With significant advancements being made in treatment of cancer particularly through development of immuno-oncology (IO) and targeted therapies, it is of equal significance to focus on supportive care in cancer so as to ensure that patients are able to complete the treatment cycle for the primary cancer as well as to enhance their quality of life. The report leverages on...
-
Sector Analysis
Country Profile: Haircare in Mexico
The Mexican haircare sector is led by the shampoo category in both value and volume terms, while the conditioner category is expected to register the fastest value and volume growth during 2017-2022. Hypermarkets & supermarkets accounted for the leading share in the distribution of haircare products in the country. Kids and babies accounted for the leading share in the consumption of haircare products in the country. Caprice, Pantène, Garnier - Fructis, Sedal and Head & Shoulders are the leading brands...
-
Sector Analysis
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU
Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more stringent scientific and value assessments and economic pressures on national budgets and health systems. Although, 5EU markets have implemented patient access schemed to ensure early access to innovative oncology medicines with high unmet need, the increasing requirements for improved clinical benefits and better cost-effectiveness of medicines has resulted in more stringent pricing and reimbursement of medicines leading to access issues such...
-
Sector Analysis
Consumer and Market Insights: Haircare in Mexico
Improving economy and a large young working population base will drive the Mexican Haircare market. The market is led by the Shampoo category, which is forecast to register fastest value growth during 2015-2020.Hypermarkets & Supermarkets is the leading distribution channel for Haircare products in the country. Rigid Plastics is the commonly used packaging material. L'Oreal S.A. and Procter & Gamble Company are the leading players in the market.
-
Sector Analysis
Mexico Haircare – Market Assessment and Forecasts to 2024
The Mexican haircare sector is led by the shampoo category in both value and volume terms, while the hair colorants category is expected to register the fastest value growth during 2019-2024. Hypermarkets & supermarkets accounted for the leading share in the distribution of haircare products in the country. Rigid plastics is the commonly used pack material in the country. Kids and babies accounted for the leading share in the consumption of haircare products in the country. Procter & Gamble, L`Oreal...
-
Sector Analysis
Myelodysplastic Syndromes – Opportunity Analysis and Forecasts to 2028
Myelodysplastic syndromes (MDS) are a relatively rare group of acquired clonal hematopoietic stem cell disorders characterized by dysfunctional hematopoiesis leading to cytopenias, with the potential to transform into acute myeloid leukemia (AML). DNA damage and mutations are the predominant factors contributing to MDS development and progression. As such, aging and the associated accumulation of mutations over time appear to be the most important risk factors for the disease. Clonal shifts in hematopoietic stem and progenitor cells due to mutations, cytogenetic...
-
Sector Analysis
Mexico Haircare – Market Assessment and Forecasts to 2023
The Mexican haircare sector is led by the shampoo category in both value and volume terms, while the styling agents category is expected to register the fastest value growth during 2018-2023. Hypermarkets & supermarkets accounted for the leading share in the distribution of haircare products in the country. Rigid plastics is the commonly used pack material in the country. Kids and babies accounted for the leading share in the consumption of haircare products in the country. Procter & Gamble, L`Oreal...